Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Patruno A et al. | 2015 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Blank M et al. | 1994 | - | magnetic field, 50/60 Hz, co-exposure | - |
Luukkonen J et al. | 2017 | intact cell/cell culture, human neuroblastoma cell line (SH-SY5Y) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Sanie-Jahromi F et al. | 2016 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 0.25–0.5 mT |
Jeong WY et al. | 2017 | - | magnetic field, 50/60 Hz, co-exposure | - |
Sanie-Jahromi F et al. | 2017 | - | magnetic field, 50/60 Hz, co-exposure | - |
Errico Provenzano A et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure | - |
Mustafa E et al. | 2021 | intact cell/cell culture, murine FDC-P1 (factor-dependent continuous - Paterson 1) hematopoietic cells | magnetic field, 50/60 Hz, co-exposure | 200 µT |
Haghighat N et al. | 2017 | - | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
Kanitz MH et al. | 2007 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, 50/60 Hz, electrotherapy, therapeutic/medical device | 1.2 µT |
Zuo H et al. | 2018 | - | magnetic field, 50/60 Hz, low frequency | - |
Zhou J et al. | 2021 | intact cell/cell culture, newborn rat calvarial osteoblasts, animal, rat/Wistar | magnetic field, 50/60 Hz, low frequency | 1.8 mT |
Drzewiecka EM et al. | 2021 | isolated organ, tissue slices, fragments of myometrium | magnetic field, 50/60 Hz, low frequency | 8 mT |
Jedrzejczak-Silicka M et al. | 2021 | intact cell/cell culture, L929 cells (murine fibroblast cells) and HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz, low frequency | 5.9–28.4 mT |
Aalami Zavareh F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, low frequency | 0.2–2 mT |
Ye AF et al. | 2022 | intact cell/cell culture, human amniotic epithelial cells (FL) | magnetic field, 50/60 Hz, low frequency | - |
Aparicio-Bautista DI et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, low frequency | - |
Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
Amirahmadi F et al. | 2023 | intact cell/cell culture, rat bone marrow-derived stem cells | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
Erdal ME et al. | 2018 | animal, rat/Wistar albino | magnetic field, 50/60 Hz, occupational | 1 mT |
Miller SC et al. | 1999 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | magnetic field, 50/60 Hz, power transmission line | 0.08–1.3 mT |
Czyz J et al. | 2004 | intact cell/cell culture, D3 (murine embryonic stem cell line, p53-deficient and wild type) | magnetic field, 50/60 Hz, power transmission line | 100 µT–2.3 mT |
Huwiler SG et al. | 2012 | bacterium, <i>Escherichia coli</i>/K12 MG1655 | magnetic field, 50/60 Hz, power transmission line | 1 mT |
Nie K et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line), MCF-7 cells (breast cancer cell line), 3Y1 cells (rat fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
Huang CY et al. | 2014 | intact cell/cell culture, HaCaT cells (human keratinocytes) partially transfected with CHK2 siRNA | magnetic field, 50/60 Hz, shielding/field deprivation | 1.5 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.